Skip to search formSkip to main contentSkip to account menu

aprepitant 40 MG Oral Capsule

Known as: APREPITANT 40MG CAP UD, APREPITANT 40 mg ORAL CAPSULE [Aprepitant], APREPITANT 40MG CAP [VA Product] 
National Institutes of Health

Related topics

Related topics

16 relations

Broader (2)

Antiemeticsaprepitant Pill
Drug AllergyGelatinNauseaOral Capsule

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Aprepitant-Formulierung mit erhöhter Löslichkeit
2014
2014
The method of preparation of aprepitant polymorph of
The present invention discloses a polymorph aprepitant preparation, comprising a compound 5- [2 (R) - [1 (R) - [3,5- bis… 
2014
2014
Flüssige orale aprepitant-formulierungen
2013
2013
Preparation of Aprepitant Nanocapsules
Objective To introduce a new preparation method of Aprepitant Nanocapsules.Methods Wet media-grinding was used to reduce drug… 
2011
2011
3068 POSTER Aprepitant is Active in Biological Therapies Induced Severe Pruritus – Final Results of the Italian Proof of Concept Study
2011
2011
術後の嘔気・嘔吐 : 選択的ニューロキニン１受容体拮抗薬が及ぼす影響
Post-operative nausea and vomiting（PONV）remains the most frequently reported patients complaint after anesthesia, and for… 
2005
2005
Arzneistoffprofile: Aprepitant - Antiemetikum einer neuen Klasse
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)